Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Douglas M. Hicks, PhD, CCC-SLP, is Director of The Voice Center and Head of the Speech-Language Pathology Section, at Cleveland Clinic.
Dr. Hicks received his undergraduate degree from The College of Wooster, his Master's degree from Northwestern University and his doctorate from Vanderbilt University. Prior to joining Cleveland Clinic, he held tenure and professorial rank at the University of Florida for nine years.
He has been actively involved in the clinical management of voice patients for more than 35 years. His invited presentations/publications are primarily related to the human voice and its disorders and number more than 360. Care of the professional voice is an area of special interest that entails active involvement with the performing arts community.
Dr. Hicks is one of the company doctors for Cleveland's Playhouse Square (the second largest performing arts center in the country), providing clinical care to performers, including those with Opera Cleveland, touring Broadway shows and pop/rock musicians. He actively works with performance faculty and students at local colleges and universities, such as Oberlin College's Conservatory of Music, where he holds an Affiliate Scholar appointment.
Dr. Hicks received the honor of Fellow from the American Speech-Language-Hearing Association. He also holds adjunct faculty positions at Case Western Reserve University and Cleveland State University.
care of the professional voice, disorders of voice, laryngeal physiology, laryngopharyngeal reflux, outcomes research, voice disorders, voice science
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/18/2014, Dr. Hicks has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Royalty Payments. Dr. Hicks receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.